Top 100 Outlook 2021: Medtechs Look To Build On Experiences Of Serving Global Markets In A Pandemic
If necessity is the mother of invention, then medtech firms know what is expected of them in 2021 ̶ how they achieve it might be less straightforward
Executive Summary
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.
You may also be interested in...
Now Available: Medtech Insight’s Top 100 Ranking Of Companies By Sales And 2021 Outlook
After a year like no other for the global medtech industry, 2021 will present a different set of market challenges for device and diagnostic companies.
Next Year’s Congress Likely To Reinforce ACA Preexisting Conditions, Attorneys Say
Industry attorneys predict that in the absence of the Supreme Court’s immediate response to arguments made in a key Affordable Care Act constitutionality case, that Congress will reaffirm the law.
50 Days To Brexit – And No Extension, Govt Warns UK Medtechs
High level EU-UK negotiations have yet to deliver a free trade deal. Meanwhile, the MHRA has issued more guidance for medtechs accessing the UK market in 2021.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: